

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 7.08694494 |
| 2 | urate metabolic process (GO:0046415) | 6.65328335 |
| 3 | phosphate ion transport (GO:0006817) | 6.56118629 |
| 4 | vitamin transmembrane transport (GO:0035461) | 6.44688985 |
| 5 | drug transport (GO:0015893) | 6.11964810 |
| 6 | phosphate ion transmembrane transport (GO:0035435) | 6.08734840 |
| 7 | surfactant homeostasis (GO:0043129) | 5.75092003 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.60336651 |
| 9 | artery development (GO:0060840) | 5.16004354 |
| 10 | lysine catabolic process (GO:0006554) | 5.08500216 |
| 11 | lysine metabolic process (GO:0006553) | 5.08500216 |
| 12 | organic cation transport (GO:0015695) | 4.89177634 |
| 13 | drug catabolic process (GO:0042737) | 4.85392983 |
| 14 | excretion (GO:0007588) | 4.72403260 |
| 15 | vitamin D metabolic process (GO:0042359) | 4.55467602 |
| 16 | sulfur compound transport (GO:0072348) | 4.54304622 |
| 17 | bile acid and bile salt transport (GO:0015721) | 4.50689479 |
| 18 | chemical homeostasis within a tissue (GO:0048875) | 4.42075600 |
| 19 | homocysteine metabolic process (GO:0050667) | 4.41802678 |
| 20 | renal absorption (GO:0070293) | 4.36474208 |
| 21 | response to mercury ion (GO:0046689) | 4.36112444 |
| 22 | vitamin transport (GO:0051180) | 4.33268907 |
| 23 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.32413734 |
| 24 | cysteine metabolic process (GO:0006534) | 4.19825075 |
| 25 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.17933804 |
| 26 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.16612241 |
| 27 | quaternary ammonium group transport (GO:0015697) | 4.15006629 |
| 28 | sulfate transmembrane transport (GO:1902358) | 4.09416182 |
| 29 | actin filament depolymerization (GO:0030042) | 4.02411406 |
| 30 | intestinal absorption (GO:0050892) | 3.97059423 |
| 31 | modified amino acid transport (GO:0072337) | 3.92385218 |
| 32 | glyoxylate metabolic process (GO:0046487) | 3.92156551 |
| 33 | glutathione biosynthetic process (GO:0006750) | 3.90800976 |
| 34 | exogenous drug catabolic process (GO:0042738) | 3.90332426 |
| 35 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.82170276 |
| 36 | flavonoid metabolic process (GO:0009812) | 3.81758700 |
| 37 | oligosaccharide catabolic process (GO:0009313) | 3.80835904 |
| 38 | phosphate ion homeostasis (GO:0055062) | 3.78333683 |
| 39 | trivalent inorganic anion homeostasis (GO:0072506) | 3.78333683 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.69056651 |
| 41 | cellular response to vitamin D (GO:0071305) | 3.60071000 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.57047033 |
| 43 | indole-containing compound catabolic process (GO:0042436) | 3.57047033 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 3.57047033 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 3.55637834 |
| 46 | lipoprotein transport (GO:0042953) | 3.49731895 |
| 47 | regulation of histone phosphorylation (GO:0033127) | 3.46462059 |
| 48 | determination of adult lifespan (GO:0008340) | 3.42082272 |
| 49 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.37549432 |
| 50 | glutathione metabolic process (GO:0006749) | 3.36672851 |
| 51 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.36080231 |
| 52 | glutathione derivative metabolic process (GO:1901685) | 3.34956759 |
| 53 | glutathione derivative biosynthetic process (GO:1901687) | 3.34956759 |
| 54 | sulfate transport (GO:0008272) | 3.33789928 |
| 55 | tricarboxylic acid metabolic process (GO:0072350) | 3.31148526 |
| 56 | aromatic amino acid family catabolic process (GO:0009074) | 3.31008786 |
| 57 | carnitine transport (GO:0015879) | 3.28483293 |
| 58 | amino-acid betaine transport (GO:0015838) | 3.28483293 |
| 59 | tryptophan metabolic process (GO:0006568) | 3.28311976 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.26239011 |
| 61 | aspartate family amino acid catabolic process (GO:0009068) | 3.24867330 |
| 62 | metanephric tubule development (GO:0072170) | 3.24321045 |
| 63 | metanephric nephron tubule development (GO:0072234) | 3.24321045 |
| 64 | kynurenine metabolic process (GO:0070189) | 3.23699991 |
| 65 | hypotonic response (GO:0006971) | 3.21004742 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.16629664 |
| 67 | bicarbonate transport (GO:0015701) | 3.15318521 |
| 68 | peptide catabolic process (GO:0043171) | 3.15203643 |
| 69 | morphogenesis of an epithelial fold (GO:0060571) | 3.13234728 |
| 70 | fatty acid oxidation (GO:0019395) | 3.10719381 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.08562321 |
| 72 | fructose metabolic process (GO:0006000) | 3.07400655 |
| 73 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05030536 |
| 74 | transepithelial transport (GO:0070633) | 3.05013054 |
| 75 | lipid oxidation (GO:0034440) | 3.04068221 |
| 76 | regulation of cholesterol metabolic process (GO:0090181) | 3.03565443 |
| 77 | neurotransmitter biosynthetic process (GO:0042136) | 3.02577044 |
| 78 | metanephric nephron epithelium development (GO:0072243) | 3.01232995 |
| 79 | drug metabolic process (GO:0017144) | 2.99325368 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 2.98484578 |
| 81 | DNA damage induced protein phosphorylation (GO:0006975) | 2.97022496 |
| 82 | peptide biosynthetic process (GO:0043043) | 2.96861618 |
| 83 | glycoside metabolic process (GO:0016137) | 2.96149715 |
| 84 | quinone biosynthetic process (GO:1901663) | 2.94884937 |
| 85 | ubiquinone biosynthetic process (GO:0006744) | 2.94884937 |
| 86 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.94675292 |
| 87 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.94675292 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.90088147 |
| 89 | L-phenylalanine metabolic process (GO:0006558) | 2.90088147 |
| 90 | angiotensin maturation (GO:0002003) | 2.89263463 |
| 91 | cellular response to vitamin (GO:0071295) | 2.88108464 |
| 92 | response to hydroperoxide (GO:0033194) | 2.86624179 |
| 93 | toxin transport (GO:1901998) | 2.83621788 |
| 94 | carnitine metabolic process (GO:0009437) | 2.82361733 |
| 95 | neural tube formation (GO:0001841) | 2.82107944 |
| 96 | metanephric epithelium development (GO:0072207) | 2.81768046 |
| 97 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.81493803 |
| 98 | azole transport (GO:0045117) | 2.79643244 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.79515743 |
| 100 | L-phenylalanine catabolic process (GO:0006559) | 2.79515743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.43145523 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.83200088 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.54531503 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22845572 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.06541780 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.03779088 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.72571154 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66629661 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.66389541 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.54290165 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50196028 |
| 12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.46204379 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.45676010 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.41960227 |
| 15 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.34942904 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31115522 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23934145 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.20768010 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06458551 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05874218 |
| 21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.93306932 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91853797 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.88925181 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.86828303 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77223639 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76852124 |
| 27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.76629189 |
| 28 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.76049877 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.69987239 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59563487 |
| 31 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57604380 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56287973 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56097468 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48176008 |
| 35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44642600 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42993021 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37092894 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35877344 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34779251 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34322464 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30647156 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30040703 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28647539 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25025950 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24703122 |
| 46 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22755610 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21259587 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19056128 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18488621 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14874605 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14596691 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13502999 |
| 53 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12656918 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12583580 |
| 55 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12176668 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11617713 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09255977 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09133537 |
| 59 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08930944 |
| 60 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08778708 |
| 61 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.06945262 |
| 62 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.04109550 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03543875 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03349875 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00744626 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00217745 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00074983 |
| 68 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98588676 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98385360 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98385360 |
| 71 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97642943 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97607673 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97403801 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96935475 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96379720 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96161788 |
| 77 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95706710 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94937099 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94498096 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93102837 |
| 81 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92919788 |
| 82 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92595532 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90906035 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90596887 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89388435 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87793038 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87706299 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86574400 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86042844 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85257805 |
| 91 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84722251 |
| 92 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84214271 |
| 93 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84214271 |
| 94 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83882781 |
| 95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80166353 |
| 96 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.79688599 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78342844 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78325954 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77944326 |
| 100 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77677333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.72427778 |
| 2 | MP0003878_abnormal_ear_physiology | 5.54655415 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 5.54655415 |
| 4 | MP0002822_catalepsy | 4.73387440 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.14877947 |
| 6 | MP0004043_abnormal_pH_regulation | 3.97013691 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.77040456 |
| 8 | MP0005257_abnormal_intraocular_pressure | 3.69860730 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.31642636 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.31103158 |
| 11 | MP0005058_abnormal_lysosome_morphology | 3.06937070 |
| 12 | MP0001765_abnormal_ion_homeostasis | 2.80218702 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.78918638 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.57611451 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.54189369 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.50537471 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.48412251 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.42277909 |
| 19 | MP0005332_abnormal_amino_acid | 2.35046182 |
| 20 | MP0005636_abnormal_mineral_homeostasis | 2.23676206 |
| 21 | MP0003283_abnormal_digestive_organ | 2.20586459 |
| 22 | MP0003252_abnormal_bile_duct | 2.18789089 |
| 23 | MP0001756_abnormal_urination | 2.10731393 |
| 24 | MP0005670_abnormal_white_adipose | 1.98280809 |
| 25 | MP0002136_abnormal_kidney_physiology | 1.88831584 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.85107414 |
| 27 | MP0001958_emphysema | 1.82611425 |
| 28 | MP0003195_calcinosis | 1.74528794 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.62871040 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.59535746 |
| 31 | MP0003941_abnormal_skin_development | 1.46285232 |
| 32 | MP0005365_abnormal_bile_salt | 1.43601451 |
| 33 | MP0001873_stomach_inflammation | 1.43195522 |
| 34 | MP0004885_abnormal_endolymph | 1.41783003 |
| 35 | MP0002796_impaired_skin_barrier | 1.41293621 |
| 36 | MP0000538_abnormal_urinary_bladder | 1.32385935 |
| 37 | MP0003724_increased_susceptibility_to | 1.32228541 |
| 38 | MP0000462_abnormal_digestive_system | 1.14459106 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.14106993 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.13630738 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.13154604 |
| 42 | MP0001663_abnormal_digestive_system | 1.10279086 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.07318054 |
| 44 | MP0005381_digestive/alimentary_phenotyp | 1.06338032 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.05824118 |
| 46 | MP0001177_atelectasis | 1.03838753 |
| 47 | MP0003385_abnormal_body_wall | 1.00578165 |
| 48 | MP0001664_abnormal_digestion | 0.99192990 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 0.98290572 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98121606 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.97075211 |
| 52 | MP0008961_abnormal_basal_metabolism | 0.96965030 |
| 53 | MP0003950_abnormal_plasma_membrane | 0.95713852 |
| 54 | MP0001661_extended_life_span | 0.95531588 |
| 55 | MP0005451_abnormal_body_composition | 0.90872858 |
| 56 | MP0004147_increased_porphyrin_level | 0.88040940 |
| 57 | MP0002254_reproductive_system_inflammat | 0.85301766 |
| 58 | MP0003866_abnormal_defecation | 0.82574723 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.82354435 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 0.81560526 |
| 61 | MP0005501_abnormal_skin_physiology | 0.81169774 |
| 62 | MP0008872_abnormal_physiological_respon | 0.80779088 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 0.78832142 |
| 64 | MP0005666_abnormal_adipose_tissue | 0.78770476 |
| 65 | MP0004272_abnormal_basement_membrane | 0.73532837 |
| 66 | MP0000477_abnormal_intestine_morphology | 0.72260289 |
| 67 | MP0008873_increased_physiological_sensi | 0.66636892 |
| 68 | MP0006054_spinal_hemorrhage | 0.63191366 |
| 69 | MP0002135_abnormal_kidney_morphology | 0.62995708 |
| 70 | MP0003186_abnormal_redox_activity | 0.60860100 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.60423632 |
| 72 | MP0003879_abnormal_hair_cell | 0.60077208 |
| 73 | MP0002896_abnormal_bone_mineralization | 0.59960721 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.59354554 |
| 75 | MP0008004_abnormal_stomach_pH | 0.59217197 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.58835174 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.58051957 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.56138519 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.55371116 |
| 80 | MP0000537_abnormal_urethra_morphology | 0.55046906 |
| 81 | MP0009384_cardiac_valve_regurgitation | 0.54722483 |
| 82 | MP0000609_abnormal_liver_physiology | 0.53400765 |
| 83 | MP0010678_abnormal_skin_adnexa | 0.52173673 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.50968195 |
| 85 | MP0005165_increased_susceptibility_to | 0.48415047 |
| 86 | MP0009840_abnormal_foam_cell | 0.48218690 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 0.46824202 |
| 88 | MP0005388_respiratory_system_phenotype | 0.46710341 |
| 89 | MP0002133_abnormal_respiratory_system | 0.46710341 |
| 90 | MP0005166_decreased_susceptibility_to | 0.46341178 |
| 91 | MP0005408_hypopigmentation | 0.45814877 |
| 92 | MP0002928_abnormal_bile_duct | 0.45598678 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.45435587 |
| 94 | MP0002168_other_aberrant_phenotype | 0.44981515 |
| 95 | MP0004484_altered_response_of | 0.43788351 |
| 96 | MP0000534_abnormal_ureter_morphology | 0.41882135 |
| 97 | MP0004947_skin_inflammation | 0.38701688 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.38030510 |
| 99 | MP0008469_abnormal_protein_level | 0.36527171 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.35588145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 7.25970447 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.74366889 |
| 3 | Increased circulating renin level (HP:0000848) | 6.32718222 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.22579634 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 6.21165780 |
| 6 | Gout (HP:0001997) | 5.74760524 |
| 7 | Hypomagnesemia (HP:0002917) | 5.54533123 |
| 8 | Hyperuricemia (HP:0002149) | 5.39466654 |
| 9 | Increased purine levels (HP:0004368) | 5.39466654 |
| 10 | Malnutrition (HP:0004395) | 5.27601244 |
| 11 | Polyuria (HP:0000103) | 5.00502531 |
| 12 | Abnormality of magnesium homeostasis (HP:0004921) | 4.91384955 |
| 13 | Proximal tubulopathy (HP:0000114) | 4.88263017 |
| 14 | Abnormality of renin-angiotensin system (HP:0000847) | 4.80083428 |
| 15 | Abnormal urine output (HP:0012590) | 4.78946186 |
| 16 | Abnormality of renal excretion (HP:0011036) | 4.64777680 |
| 17 | Hyperaldosteronism (HP:0000859) | 4.58877017 |
| 18 | Abnormality of purine metabolism (HP:0004352) | 4.51527231 |
| 19 | Alkalosis (HP:0001948) | 4.46420680 |
| 20 | Renal salt wasting (HP:0000127) | 4.34337746 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.28714828 |
| 22 | Tetany (HP:0001281) | 4.17885554 |
| 23 | Generalized aminoaciduria (HP:0002909) | 4.10475003 |
| 24 | Abnormal drinking behavior (HP:0030082) | 3.86842597 |
| 25 | Polydipsia (HP:0001959) | 3.86842597 |
| 26 | Hypokalemia (HP:0002900) | 3.51261971 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 3.33681451 |
| 28 | Glycosuria (HP:0003076) | 3.33681451 |
| 29 | Dehydration (HP:0001944) | 3.31959039 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.29443062 |
| 31 | Prostate neoplasm (HP:0100787) | 3.26722339 |
| 32 | Hyperglycinuria (HP:0003108) | 3.26630102 |
| 33 | Oligomenorrhea (HP:0000876) | 3.21851224 |
| 34 | Hypercalciuria (HP:0002150) | 3.12818831 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08624027 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 2.93198993 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 2.89030098 |
| 38 | Abnormality of potassium homeostasis (HP:0011042) | 2.85217241 |
| 39 | Hydroxyprolinuria (HP:0003080) | 2.79714311 |
| 40 | Abnormality of proline metabolism (HP:0010907) | 2.79714311 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72059675 |
| 42 | Thin bony cortex (HP:0002753) | 2.66240646 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 2.65917006 |
| 44 | Hyponatremia (HP:0002902) | 2.50948235 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.50476185 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.50476185 |
| 47 | Abnormality of sodium homeostasis (HP:0010931) | 2.45307276 |
| 48 | Renal tubular acidosis (HP:0001947) | 2.42148287 |
| 49 | Xanthomatosis (HP:0000991) | 2.41980976 |
| 50 | Hyperphosphaturia (HP:0003109) | 2.40778702 |
| 51 | Flat acetabular roof (HP:0003180) | 2.40744269 |
| 52 | Nephrolithiasis (HP:0000787) | 2.40531313 |
| 53 | Glomerulosclerosis (HP:0000096) | 2.37244513 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.36648817 |
| 55 | Tubulointerstitial fibrosis (HP:0005576) | 2.36184452 |
| 56 | Confusion (HP:0001289) | 2.36176844 |
| 57 | Abnormality of the costochondral junction (HP:0000919) | 2.34474280 |
| 58 | Ileus (HP:0002595) | 2.33947648 |
| 59 | Metaphyseal cupping (HP:0003021) | 2.29038489 |
| 60 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.28680576 |
| 61 | Villous atrophy (HP:0011473) | 2.28680576 |
| 62 | Ketoacidosis (HP:0001993) | 2.25975383 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25402655 |
| 64 | Tubular atrophy (HP:0000092) | 2.25175746 |
| 65 | Rickets (HP:0002748) | 2.25041198 |
| 66 | Abnormal urine phosphate concentration (HP:0012599) | 2.22510161 |
| 67 | Adrenal overactivity (HP:0002717) | 2.22111721 |
| 68 | Hypophosphatemia (HP:0002148) | 2.16505584 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.13274328 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13274328 |
| 71 | Cupped ribs (HP:0000887) | 2.13226406 |
| 72 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08970248 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.07493404 |
| 74 | Abnormality of carpal bone ossification (HP:0006257) | 2.06237433 |
| 75 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.05144916 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.04542115 |
| 77 | Nausea (HP:0002018) | 2.04412996 |
| 78 | Pustule (HP:0200039) | 2.04171599 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.01062905 |
| 80 | Abdominal distention (HP:0003270) | 1.95769656 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 1.95293839 |
| 82 | Decreased circulating renin level (HP:0003351) | 1.89954434 |
| 83 | Metaphyseal irregularity (HP:0003025) | 1.87642615 |
| 84 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.86628823 |
| 85 | Neonatal short-limb short stature (HP:0008921) | 1.86594168 |
| 86 | Hypotension (HP:0002615) | 1.86337793 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 1.86152836 |
| 88 | Vascular calcification (HP:0004934) | 1.84904375 |
| 89 | Ketosis (HP:0001946) | 1.84365512 |
| 90 | Bicornuate uterus (HP:0000813) | 1.82444041 |
| 91 | Dysostosis multiplex (HP:0000943) | 1.80123586 |
| 92 | Abnormal tarsal ossification (HP:0008369) | 1.79904988 |
| 93 | Nephrocalcinosis (HP:0000121) | 1.79052879 |
| 94 | Hyperammonemia (HP:0001987) | 1.79048433 |
| 95 | Chondrocalcinosis (HP:0000934) | 1.76830656 |
| 96 | Vomiting (HP:0002013) | 1.76507661 |
| 97 | Enlarged epiphyses (HP:0010580) | 1.74111725 |
| 98 | Visceral angiomatosis (HP:0100761) | 1.73711658 |
| 99 | Hypoalphalipoproteinemia (HP:0003233) | 1.72725633 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.70298864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 5.85966909 |
| 2 | WNK4 | 4.79630055 |
| 3 | MAP3K2 | 4.34442201 |
| 4 | MET | 3.90990083 |
| 5 | KSR2 | 3.80981091 |
| 6 | OXSR1 | 3.58107645 |
| 7 | WNK3 | 2.98918573 |
| 8 | STK39 | 2.62940347 |
| 9 | MAP2K2 | 2.23232274 |
| 10 | MST1R | 10.1242296 |
| 11 | NME1 | 1.98206022 |
| 12 | MST4 | 1.53673314 |
| 13 | MAP2K1 | 1.51336716 |
| 14 | LMTK2 | 1.47963083 |
| 15 | FRK | 1.40491507 |
| 16 | WNK1 | 1.39603710 |
| 17 | MAP3K1 | 1.17856952 |
| 18 | TBK1 | 0.96030120 |
| 19 | TGFBR1 | 0.87975367 |
| 20 | CDK9 | 0.86255510 |
| 21 | ACVR1B | 0.83924550 |
| 22 | EPHB1 | 0.80738796 |
| 23 | GRK6 | 0.79281163 |
| 24 | MAP3K8 | 0.78845872 |
| 25 | RET | 0.77007062 |
| 26 | PDK2 | 0.70245234 |
| 27 | EPHB2 | 0.69578100 |
| 28 | PRKG2 | 0.67162174 |
| 29 | MYLK | 0.63362360 |
| 30 | BCKDK | 0.61898406 |
| 31 | PTK2 | 0.60035085 |
| 32 | TIE1 | 0.59779913 |
| 33 | EEF2K | 0.59685702 |
| 34 | PAK4 | 0.57013036 |
| 35 | STK38L | 0.56712591 |
| 36 | BMPR1B | 0.56498321 |
| 37 | TESK1 | 0.54750526 |
| 38 | NEK1 | 0.54209326 |
| 39 | LRRK2 | 0.53892995 |
| 40 | CAMK2D | 0.52985960 |
| 41 | FGFR4 | 0.49299677 |
| 42 | PDK3 | 0.49009001 |
| 43 | PDK4 | 0.49009001 |
| 44 | IKBKE | 0.47312781 |
| 45 | FER | 0.46325968 |
| 46 | TGFBR2 | 0.45860745 |
| 47 | TAOK3 | 0.45848399 |
| 48 | PTK6 | 0.44863724 |
| 49 | KDR | 0.44602511 |
| 50 | PDPK1 | 0.41924893 |
| 51 | FGFR2 | 0.38929918 |
| 52 | SGK223 | 0.35856603 |
| 53 | SGK494 | 0.35856603 |
| 54 | MAP3K12 | 0.33005292 |
| 55 | PTK2B | 0.31807128 |
| 56 | JAK2 | 0.30858114 |
| 57 | MAP3K3 | 0.30466865 |
| 58 | IGF1R | 0.28358826 |
| 59 | STK10 | 0.25928343 |
| 60 | EPHA3 | 0.25873626 |
| 61 | DMPK | 0.25070195 |
| 62 | IRAK2 | 0.24246243 |
| 63 | ERN1 | 0.24135722 |
| 64 | MAP3K14 | 0.24108179 |
| 65 | IRAK1 | 0.23815436 |
| 66 | RIPK1 | 0.22093959 |
| 67 | PDK1 | 0.21506347 |
| 68 | MAPKAPK3 | 0.19334653 |
| 69 | GSK3A | 0.19274272 |
| 70 | MAPK11 | 0.18473606 |
| 71 | EPHA2 | 0.18370870 |
| 72 | NUAK1 | 0.17252223 |
| 73 | SCYL2 | 0.17016356 |
| 74 | STK38 | 0.16685989 |
| 75 | MELK | 0.13403806 |
| 76 | CSK | 0.12484330 |
| 77 | PAK3 | 0.12457491 |
| 78 | PRKCA | 0.11811713 |
| 79 | ROCK1 | 0.11696752 |
| 80 | SRC | 0.11529409 |
| 81 | DDR2 | 0.10939078 |
| 82 | DYRK1B | 0.10628273 |
| 83 | LIMK1 | 0.09984798 |
| 84 | PRKCI | 0.06652810 |
| 85 | PRKAA2 | 0.06559829 |
| 86 | ITK | 0.06505734 |
| 87 | ADRBK1 | 0.05980194 |
| 88 | MAP3K7 | 0.05293997 |
| 89 | SGK1 | 0.05230089 |
| 90 | MAP3K11 | 0.04117447 |
| 91 | ERBB2 | 0.03913486 |
| 92 | PIK3CG | 0.03907676 |
| 93 | MATK | 0.03895979 |
| 94 | FYN | 0.03750807 |
| 95 | NTRK1 | 0.03271964 |
| 96 | PRKACG | 0.02935180 |
| 97 | TRIB3 | 0.01823724 |
| 98 | RPS6KB2 | 0.01587200 |
| 99 | PRKAA1 | 0.01138900 |
| 100 | SGK3 | 0.00701129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.87169294 |
| 2 | * Mineral absorption_Homo sapiens_hsa04978 | 3.85138854 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.00215254 |
| 4 | Bile secretion_Homo sapiens_hsa04976 | 2.87219069 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.77212940 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.60806542 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.33417405 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32811320 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.25627300 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17601524 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.17424656 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12789287 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04640403 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.03642506 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95516312 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88865240 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80171652 |
| 18 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.65300242 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63507649 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62170276 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60054381 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59119489 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.58918819 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56274290 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51718002 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51156261 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.49564721 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41687055 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41558913 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.37715360 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37472818 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36510725 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36505928 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36134315 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29961366 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26017780 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24104236 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22146873 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20376447 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19172971 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17965272 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12079848 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10995403 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03941694 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02579450 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02267106 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99614962 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99015530 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97436080 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.95137830 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89464888 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.89288629 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87784056 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.87303139 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86545465 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84647687 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84457851 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81635173 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76991292 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70170087 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68823685 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.68556267 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64391567 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64094324 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63860794 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63451559 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.61463255 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57256124 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56414747 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51044122 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49976512 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47599797 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45997965 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.45611098 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39437747 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39003526 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37514004 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37336239 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.36802036 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33751804 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33452117 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32290512 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32232221 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31465937 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31092014 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30856645 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30846385 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30838657 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30301223 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29181431 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.26772614 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24896950 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20716875 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.19752604 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18881221 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17845943 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.17349242 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17019019 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15989532 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15198516 |

